|
29 Mar 2007 |
Wockhardt receives US FDA approval for diuretic injection, Second FDA approval in a week
|
|
29 Mar 2007 |
Samaritan Pharma Partners PII HIV Drug to Pharmaplaz; Upfront Payment $10 Million
|
|
28 Mar 2007 |
Seattle Genetics Announces Extension of Antibody-Drug Conjugate Collaboration with Genentech
|
|
28 Mar 2007 |
Taro Receives Tentative Approval for Ciclopirox Topical Solution, 8% (Nail Lacquer) ANDA
|
|
28 Mar 2007 |
BrainCells Inc. and Lundbeck Form CNS Drug Research Collaboration
|
|
28 Mar 2007 |
Acuity Pharmaceuticals and Froptix Corporation Agree to Mergers with Public Shell; New Company to Develop and Market Drugs for Disorders of the Eye
|
|
27 Mar 2007 |
Schering-Plough and Merck to Develop Another New Cholesterol Lowering Medicine
|
|
27 Mar 2007 |
Novartis to launch its own branded version of a leading multiple sclerosis therapy through agreement with Bayer Schering Pharma
|
|
27 Mar 2007 |
Cephalon, Inc. (CEPH) Files Marketing Application for Approval of a Fentanyl Effervescent Buccal Tablet in Europe
|
|
24 Mar 2007 |
NovaDel's European Formulation of Ondansetron Targeted for U.S. Zensana(TM)
|
|
23 Mar 2007 |
Topigen and Novagali enter into strategic collaboration for allergic ocular diseases and allergic rhinitis
|
|
23 Mar 2007 |
Pain Therapeutics Licenses Biotechnology To Treat Rare Disorder
|
|
23 Mar 2007 |
Cubist Pharmaceuticals Licenses Rights for Development and Commercialization of CUBICIN in Japan to Merck & Co., Inc.
|
|
23 Mar 2007 |
MilleGen and LFB Sign Research Partnership Agreement to Develop New Generation of Therapeutic Monoclonal Antibodies
|
|
23 Mar 2007 |
VASTox plc Acquires DanioLabs Ltd and Dextra Laboratories Ltd to Strengthen Its Drug Discovery Pipeline and Pharmaceutical Services Business
|
|
22 Mar 2007 |
Fralex Therapeutics Inc. initiates pivotal trial for chronic pain associated with fibromyalgia
|
|
22 Mar 2007 |
BioLineRx In-Licenses Novel Peptide for the Treatment of Inflammatory Diseases
|
|
22 Mar 2007 |
Medtronic Announces Strategic Agreement with Osteogenix, Incorporated
|
|
22 Mar 2007 |
Synovics Pharmaceuticals Files ANDA for Generic Hydroxyzine
|
|
22 Mar 2007 |
Eisai's Dramatic Leap towards Biologic Therapeutics Evidenced by the Acquisition
|
|
21 Mar 2007 |
Abraxis BioScience to Initiate Two Phase I/II Clinical Trials with nab-docetaxel in Hormone Refractory Prostate and Metastatic Breast Cancer
|
|
21 Mar 2007 |
Wockhardt to market painkiller in the US, Sixteenth US FDA-approved product
|
|
21 Mar 2007 |
GenVec Signs Cooperative Research and Development Agreement (CRADA) with the National Institute of Allergy and Infectious Diseases (NIAID) to Develop RSV Vaccines
|
|
21 Mar 2007 |
Dharma Therapeutic Shows IDDS is Effective in Reducing Pain Associated with Insertion of an Intravenous Catheter in their Phase 2 Clinical Trial
|
|
21 Mar 2007 |
Cannasat Therapeutics and IntelGenx Enter Into Agreement to Develop Cannabinoid-Based Products for the Treatment of Mood Disorders Such as Anxiety and Depression
|
